He hoped to sell higher volumes of obesity and diabetes drugs over the coming years, saying: We are seeing a volume response to lower prices. He pointed to Novos agreement with the Trump administration to cut prices heavily, from more than $1,000 a month (730) to an average price of $350 (255), and the patent expiry of semaglutide, the main ingredient of its obesity and diabetes drugs, in several countries including India
Diurnal changes of biochemical metabolic markers in healthy young males - the Bispebjerg study of diurnal variations
Nature 360 , 467471 (1992)
Snell V, Consoli U, Hude K, Mills G, Andreeff M
Patients should also be taught simple strategies to reduce side effects, such as drinking more fluids, increasing fiber slowly, and adjusting food choices when symptoms flare
Overview of the physiological control of eating